Last updated: August 4, 2025
Introduction
Patent WO2012142367, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention with potential therapeutic applications. As an essential element in drug development, patent analysis facilitates understanding of the innovation's scope, scope of claims, and positioning within the current patent landscape. This report provides an exhaustive analysis, aimed at business professionals, patent strategists, and R&D leaders, to comprehend the implications, territorial coverage, and potential for patent infringement or licensing opportunities.
Patent Overview
WO2012142367 was published on November 8, 2012, revealing a molecular entity or formulation designed for specific pharmaceutical applications. The patent application is likely related to a compound, formulation, or therapeutic method, typical of WIPO filings, with the intent to secure rights across multiple jurisdictions through the PCT route.
While the detailed technical disclosures are proprietary, the key focus is on the language of claims, the scope of protection, and how the patent interacts within the patent landscape of therapeutically relevant compounds.
Scope of the Patent
1. Patent Territory and Coverage
WO2012142367, as a WIPO International Patent Application, provides a basis for national phase filings in multiple jurisdictions, including the United States, European Patent Office (EPO), Japan, China, and others. The scope of protection in each jurisdiction depends on national prosecution decisions; however, the initial WIPO publication indicates a broad territorial intent.
2. Subject Matter
The patent is primarily directed toward:
- Chemical compounds with specified structural features.
- Pharmaceutical formulations incorporating the compounds.
- Therapeutic methods for treating particular medical conditions, possibly related to inflammation, cancer, or infectious diseases.
The broad chemical and method claims indicate an overarching aim to protect novel molecules or combinations, and their specific uses.
Analysis of Claims
1. Claim Scope
The claims provide the legal boundaries of the patent; they define what is protected from infringement. Based on typical patent applications of this nature, the claims likely encompass:
- Compound Claims: Specific chemical structures or classes with defined substitutions.
- Use Claims: Method of using the compounds for treating particular conditions.
- Formulation Claims: Pharmaceutical compositions comprising the claimed compounds with specific carriers or excipients.
Given the typical structure of such patents, the claims might include both narrow and broad language, with some covering specific compounds and others broader classes or methods.
2. Narrow vs. Broad Claims
- Narrow Claims: Focused on specific molecules with defined chemical formulas, serving as a solid basis for enforcement but offering limited scope.
- Broad Claims: Encompase wider chemical classes or therapeutic methods, providing strategic coverage but potentially vulnerable to validity challenges.
The scope balance influences patent strength: broad claims can restrict competitors but risk ease of invalidation; narrower claims are more enforceable but less deterrent.
3. Claim Dependencies
Dependent claims likely specify embodiments or particular use cases, such as dosage forms, routes of administration, or specific therapeutic indications, adding layers of protection.
Patent Landscape and Competitive Positioning
1. Prior Art and Novelty
Critical to a patent’s strength is novelty against existing prior art. Patent searches reveal that compounds in the same class, or similar therapeutic methods, may have existing patents or publications. The novelty hinges on unique structural features, specific substitutions, or unexpected therapeutic effects.
2. Patent Families and Related Applications
WO2012142367 forms part of a larger patent family, possibly linked to earlier provisional applications or related filings. Examining family members clarifies the scope evolution and geographic rights.
3. Landscape Analysis
The patent landscape involves identifying:
- Competitor Patents: Other filings covering similar compounds, methods, or therapeutic applications.
- Freedom-to-Operate (FTO): Whether the claims infringe existing patents or vice versa.
- Potential Infringements: Assessments of conflicting patents that could impact commercialization.
This landscape features numerous patents in the pharmaceutical compound classes, with overlapping claims, necessitating detailed freedom-to-operate analyses before product development.
4. Patent Trends
The field of drug patenting around WO2012142367 typically exhibits:
- Increasing filings over several years, indicating growth and interest.
- Cross-jurisdictional patenting to block competitors.
- Strategic continuation filings refining claim scopes.
Legal and Strategic Implications
- Patent Validity: The strength depends on prior art analysis and the clarity of claim language.
- Patent Term and Life Cycle: Given the 2012 publication date, patent rights are set to expire around 2032-2033, considering typical 20-year terms.
- Enforceability Risks: Broad claims or overlapping prior art could compromise enforceability.
- Licensing and Partnerships: The patent's scope makes it attractive for licensing deals, especially if the claims cover widely used therapeutic classes.
Conclusion
WO2012142367 represents a strategically significant patent, potentially blocking competitors or establishing a strong foothold in its therapeutic area. Its scope spans chemical compounds, formulations, and therapeutic methods, with claims crafted to protect core innovations while balancing breadth with robustness. The patent landscape surrounding it is competitive and complex, requiring ongoing monitoring and legal scrutiny.
Key Takeaways
- Broad Coverage: The patent aims to protect specific chemical entities, their formulations, and therapeutic uses, providing comprehensive protection in multiple jurisdictions.
- Claims Strategy: Its claims balance narrow specificity to withstand validity challenges with broad language to deter competitors.
- Landscape Positioning: The patent resides within a crowded technology space; strategic patent family management and freedom-to-operate analyses are critical before commercialization.
- Lifecycle Considerations: Exploitation depends on maintaining patent validity, monitoring potential challenges, and leveraging licensing opportunities.
- Business Implication: The patent’s territorial coverage and claim strength make it a valuable asset for licensing, partnership negotiations, or exclusive rights in the targeted therapeutic field.
FAQs
1. What is the primary focus of patent WO2012142367?
It covers novel chemical compounds, formulations, and therapeutic methods, likely related to targeted disease treatment. Its broad claims suggest protection over both the compounds and their medical applications.
2. How does this patent influence the competitive landscape?
It secures a strategic market position by blocking competitors from developing similar compounds or use methods within jurisdictions where it is filed, thereby creating opportunities for licensing or exclusive marketing rights.
3. What are the risks associated with patent infringement?
Due to overlapping claims in the same chemical or therapeutic space, there is a risk of infringement litigation if other patents claim similar compounds or methods, emphasizing the need for a thorough freedom-to-operate analysis.
4. How do claim language and scope affect patent strength?
Narrow claims improve enforceability but limit scope; broad claims cover more but are vulnerable to invalidation. Well-crafted claims balance these factors for maximum strategic benefit.
5. What should companies consider before investing in development based on this patent?
Assessing the patent’s validity, its enforceability, and the patent landscape, including potential challenges and licensing opportunities, is crucial for informed decision-making.
References
[1] WIPO Patent WO2012142367.
[2] PatentScope, WIPO. "International Patent Application Publications," 2012.
